Literature DB >> 14012535

Studies on hyaline membrane disease. I. The fibrinolysin system in pathogenesis and therapy.

C M AMBRUS, D H WEINTRAUB, D DUNPHY, J E DOWD, J W PICKREN, K R NISWANDER, J L AMBRUS.   

Abstract

Keywords:  FIBRINOLYSIN; FIBRINOLYSIS; HYALINE MEMBRANE DISEASE; STREPTODORNASE AND STREPTOKINASE

Mesh：

Substances：

Year:  1963        PMID： 14012535

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

1.  Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein.

Authors:  J M Edelberg; J J Enghild; S V Pizzo; M Gonzalez-Gronow
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

2.  Localization of plasminogen activator in neonatal lung in the presence of hyaline membrane disease.

Authors:  J T Roberts
Journal:  J Clin Pathol       Date:  1965-09       Impact factor: 3.411

3.  Physiological activation of plasminogen in full term newborn infants.

Authors:  M M Hilali; B E Gilliver
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

4.  Current concepts on respiratory distress syndrome in the newborn (hyaline membrane disease).

Authors:  M C Hart
Journal:  Can Fam Physician       Date:  1970-11       Impact factor: 3.275

5.  [Experimental studies on proteolysis of hyaline membranes in vitro (author's transl)].

Authors:  D Harms; G Buss; N Heimburger; G R Pape
Journal:  Klin Wochenschr       Date:  1975-12-15

6.  Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates.

Authors:  W van den Berg; C Breederveld; J W ten Cate; M Peters; J J Borm
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

7.  Haemostatic disorders and respiratory distress in the newborn.

Authors:  C Boyer; D Ménaché; F Beaufils; H Mathieu
Journal:  Intensive Care Med       Date:  1977-12       Impact factor: 17.440

8.  Fibrin-fibrinogen degradation products in sera of normal infants and children.

Authors:  W S Uttley; A G Allan; J D Cash
Journal:  Arch Dis Child       Date:  1969-12       Impact factor: 3.791
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.